Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L Weber

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Annals of Surgical Oncology|September 23, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Genome Biology|March 26, 2009
Integrated analysis of breast cancer cell lines reveals unique signaling pathwaysLaura M Heiser, Nicholas J Wang, Carolyn L Talcott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
The Journal of Clinical Investigation|April 15, 2010
HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotypePenney M Gilbert, Janna K Mouw, Meredith A Unger, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
American Journal of Human Genetics|March 1, 2003
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityMieke Schutte, Sheila Seal, Rita Barfoot, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
microRNAs exhibit high frequency genomic alterations in human cancerLin Zhang, Jia Huang, Nuo Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxelKeith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.
Cancer Biology & Therapy|March 12, 2009
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissuesChangqing Ma, Kelly M Quesnelle, Anthony Sparano, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Annals of Surgical Oncology|September 23, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Genome Biology|March 26, 2009
Integrated analysis of breast cancer cell lines reveals unique signaling pathwaysLaura M Heiser, Nicholas J Wang, Carolyn L Talcott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
The Journal of Clinical Investigation|April 15, 2010
HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotypePenney M Gilbert, Janna K Mouw, Meredith A Unger, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
American Journal of Human Genetics|March 1, 2003
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityMieke Schutte, Sheila Seal, Rita Barfoot, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
microRNAs exhibit high frequency genomic alterations in human cancerLin Zhang, Jia Huang, Nuo Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxelKeith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.
Cancer Biology & Therapy|March 12, 2009
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissuesChangqing Ma, Kelly M Quesnelle, Anthony Sparano, et al.
Pageof 9